INVO Fertility, Inc. (IVF)vsStryker Corporation (SYK)
IVF
INVO Fertility, Inc.
$0.56
-9.74%
HEALTHCARE · Cap: $2.62M
SYK
Stryker Corporation
$304.00
+2.55%
HEALTHCARE · Cap: $113.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 342971% more annual revenue ($25.84B vs $7.53M). SYK leads profitability with a 14.4% profit margin vs -92.3%. SYK earns a higher WallStSmart Score of 67/100 (B-).
IVF
Hold37
out of 100
Grade: F
SYK
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for IVF.
Margin of Safety
-33.2%
Fair Value
$229.90
Current Price
$304.00
$74.10 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
16.7% revenue growth
Large-cap with strong market position
Strong operational efficiency at 27.0%
Earnings expanding 44.1% YoY
Generating 1.1B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
Premium valuation, high expectations priced in
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : IVF
The strongest argument for IVF centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap, Operating Margin, EPS Growth. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : IVF
The primary concerns for IVF are EPS Growth, Market Cap, Return on Equity.
Bear Case : SYK
The primary concerns for SYK are P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
IVF profiles as a growth stock while SYK is a value play — different risk/reward profiles.
IVF carries more volatility with a beta of 1.44 — expect wider price swings.
IVF is growing revenue faster at 16.7% — sustainability is the question.
SYK generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (67/100 vs 37/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
INVO Fertility, Inc.
HEALTHCARE · MEDICAL DEVICES · USA
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. The company is headquartered in Sarasota, Florida.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?